[1]
2022. Vismodegib as a Treatment for Multiple Non-locally Advanced Basal Cell Carcinomas. SKIN The Journal of Cutaneous Medicine. 6, 5 (Sep. 2022), 421–423. DOI:https://doi.org/10.25251/skin.6.5.13.